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1607-551X/Copyright ª 2015, KaohsiuAbstract Tc-99m phytate hepatic scintigraphy remains the standard method for evaluating
the functional features of Kupffer cells. In this study, we demonstrate the variable uptake
feature of focal nodular hyperplasia (FNH) in Tc-99m phytate scintigraphy. We reviewed all
patients who underwent Tc-99m phytate hepatic scintigraphy between 2008 and 2012 in
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Cases with FNH were diagnosed
on the basis of pathology or at least one or more prior imaging with a periodic clinical
follow-up. All patients received a standard protocol of dynamic flow study and planar and
Tc-99m phytate single-photon emission computed tomography (E. CAM; Siemens). The cor-
relation of variable nodular radioactivity with parameters such as tumor size and localiza-
tion was analyzed. In total, 15 lesions of 14 patients in the clinic were diagnosed as FNH.
The tumor size was approximately 2.9e7.4 cm (mean size 4.6 cm). Four lesions were larger
than 5 cm. The major anatomic distribution was in the right hepatic lobe (10 lesions), partic-
ularly in the superior segments (7 lesions). Tc-99m phytate single-photon emission computed
tomography imaging for determining the functional features of Kupffer cells included cool/
cold (8 lesions), isoradioactive/warm (6 lesions), and hot (1 lesion) patterns of uptake. We
did not observe any statistically significant correlation between variable nodulareclare no conflicts of interest.
of Nuclear Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
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622 Y.-L. Hsu et al.radioactivity and tumor size (pZ 0.68) or localization (pZ 0.04). Herein, we demonstrate
the variable uptake feature of FNH in Tc-99m phytate scintigraphy. In small FNH tumors
(< 5 cm), increased or equal uptake still provided specificity for the differential diagnosis
of hepatic solid tumors.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Focal nodular hyperplasia (FNH) is the second most common
benign solid liver tumor; it constitutes approximately 8% of
all primary hepatic neoplasms and is present in 0.3e3% of the
general population [1e3]. These tumors are most frequently
diagnosed in women (10:1) aged 20e50 years [4]. At present,
the pathophysiology of FNH remains unclear. However, a new
hypothesis posits that FNH genesis is secondary to vascular
malformation, which produces hyperperfusion in the area of
hepatic parenchyma, which determines a hyperplastic
response to this phenomenon without the risk of malignant
transformation [1,5] or bleeding, thus eliminating the need
for aggressive treatment [6,7].
Patients with FNH are asymptomatic and identified
incidentally during imaging. However, approximately 25% of
patients initially exhibit related symptoms, such as
epigastric pain or a palpable mass. The absolute differen-
tial diagnosis with other solid hypervascular hepatic tu-
mors, such as hepatic cellular adenoma or hepatic cellular
carcinoma, remains difficult. Contrast computed tomogra-
phy (CT) and magnetic resonance imaging (MRI) scans are
the choices for detecting the typical features, such as a
uniform pattern of hypervascularity after contrast
enhancement and a central scar of fibrovascular tissue, for
FNH diagnosis. Unfortunately, these typical features are
not always present [8,9]. In a study of 305 patients with
FNH, Nguyen et al. [10] reported that a central scar was
only found in approximately 50% of the cases.
Hepatic scintigraphy with Tc-99m sulfur colloid or phy-
tate provides specificity for FNH diagnosis. Findings
revealed that, compared with CT, MRI, or ultrasound,
phytate imaging reveals the typical characteristics of solid
tumors more effectively because of the increased or equal
uptake of radiopharmaceuticals by the tumors, called “hot
or warm nodules,” compared with adjacent hepatic tissues.
Although its use in Taiwan is decreasing, Tc-99m phytate
hepatic scintigraphy remains an excellent tool for evalu-
ating the functional status of Kupffer cells. In this paper,
we include several cases with FNH demonstrating the var-
iable uptake feature in Tc-99m phytate hepatic scintig-
raphy and propose a hypothesis for these phenomena
according to a recent literature review.Methods
We reviewed all patients who underwent Tc-99m phytate
(off-label usage) hepatic scintigraphy in Kaohsiung MedicalUniversity Hospital, Kaohsiung, Taiwan, between 2008 and
2012. In total, 25 patients were reviewed. Among them,
five patients, diagnosed with hepatocellular carcinoma
(HCC), were excluded. The inclusion criteria for FNH
included cases diagnosed on the basis of pathology; those
with at least one CT, MRI, or ultrasound supporting diag-
nosis; or those clinically treated for FNH with a long-term
follow-up. In total, 14 patients with 15 lesions were
included. After intravenous injection of 6mCi Tc-99m phy-
tate, all patients underwent a standard protocol of Tc-99m
phytate hepatic scintigraphy as a dynamic flow study (2
seconds per frame, 32 frames), planar imaging (anterior,
posterior, and lateral views), and single-photon emission
computed tomography (SPECT; E. CAM; Siemens,
Cleveland, Ohio, USA). All imaging was reviewed by at least
two experienced nuclear medicine physicians. According to
the tumor sphere-growth theory, the size of the mass is
represented as a volume estimated on the basis of the
greatest length of the mass in ultrasound or CT imaging.
Compared with adjacent hepatic parenchyma, tumor
masses were classified on a 5-point scale as exhibiting a
cold, cool, isoradioactive, warm, or hot pattern on the
basis of their radioactivity uptake in single-photon imaging.
Following a statistical analysis, we performed a Chi-square
test and multiple linear regressions to analyze correlations
between all the parameters.
Results
We recruited 14 patients diagnosed with FNH who had a
total of 15 lesions. Nine of the patients (64%) were women
and the rest (36%) were men. One woman had two lesions.
The age range was from 23 years to 45 years, with a mean
age of 31.6 6.2 years. The tumor size ranged from 2.9 cm
to 7.4 cm, with a mean size of 4.6 1.5 cm. Among the
lesions, 11 were smaller than 5 cm (73%). In the dynamic
flow study, we found that only two lesions (13%) had a
hyperhepatic flow. The lesions were classified among five
groups by comparing their uptake features with those of
hepatic parenchyma: four (26.7%) were cold lesions, four
(26.7%) cool lesions, three (20%) isoradioactive lesions,
three (20%) warm lesions, and one (6.7%) a hot lesion. Thus,
seven lesions (46.7%) satisfied the diagnostic criteria for
FNH. Figure 1 shows the typical features of “warm and cold
nodules.” The anatomical distribution of these lesions is as
follows: one in the liver segment S1/2 (7%); four in S3/4
(27%); three in S5/6 (20%); and seven in S7/8 (46%) of the
liver. Most of the lesions were located in the liver segment
S7/8 (Figure 2).
Figure 1. (A) Case with an “isoradioactive or warm” lesion in S5 (as indicated by the arrow); labeled as “score 3.” (B) Case with a
“cold” pattern in S7 (as indicated by the arrow); labeled as “score 1.”
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patient age, tumor location, tumor size, and tumor radio-
activity. We analyzed the correlation between all these
parameters by performing the Chi-square test and multiple
linear regressions. All the tumors were given one of the five
scores: score 1 (cold), 2 (cool), 3 (isoradioactive), 4 (warm),
or 5 (hot). Various cutoff values were used for the statistical
analysis. The p values were also calculated. No statisticallyFigure 2. Distribution of tumors: most focal nodular hyper-
plasia lesions in our cases are localized in superior segments of
the right hepatic lobe.significant correlation was observed between the radioac-
tivity uptake feature of hepatic tumors and tumor size or
localization (Figures 3 and 4).
Discussion
Kupffer cells in hepatic sinusoids were first discovered by
Carl Wilhelm von Kupffer (1865). These cells, belonging to
the mononuclear phagocyte system, constitute the largest
tissue macrophage population in the body (80e90%) [11].
Thus, hepatic uptake is the major uptake seen afterFigure 3. Correlation between tumor size and radioactivity
score.
Figure 4. Correlation between segments with localized he-
patic tumors and radioactivity scores.
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healthy people. The liver is an immunological organ [12].
Kupffer cells exhibit various mechanisms, such as phago-
cytosis, metabolism, cytokine generation, and antitumor
effects. In addition, these cells play a crucial role in the
host defense mechanism and in maintaining homeostasis
[13e15]. Kupffer cells can be classified into two types on
the basis of topological and functional heterogeneity. Large
Kupffer cells are located in the periportal zone and respond
to incoming molecular signals; therefore, they exhibit
higher phagocytosis, lysosomal protease activity, and
output of biologically active mediators than smaller Kupffer
cells in the midzonal and perivenous areas [15e17]. A liver
impairment (e.g., hepatitis or cirrhosis) is speculated to
reduce the functional capacity of Kupffer cells [18].
Recently, the functional capacity of M1/M2 Kupffer cells
was found to play a role in the potential mechanism of
alcoholic/nonalcoholic fatty liver disease [15,19,20].
As mentioned, a new hypothesis posits that FNH genesis
is secondary to vascular malformation, which produce
hyperperfusion in the area of hepatic parenchyma. There-
fore, alternative Kupffer cells in the affected region will
likely change in number or functional capacity. The func-
tional features of Kupffer cells in FNH can be properly
demonstrated using Tc-99m phytate hepatic scintigraphy.
Phytate uptake was normal in approximately 60e75% of
cases, reduced in 25e30% of cases, and increased in 5e10%
of cases, reflecting a variable number of Kupffer cells
[21e24]. Among our 15 cases, eight (53%) exhibited reduced
phytate uptake, three (20%) normal uptake, and four (27%)
increased uptake. The varied distribution could be due to a
variation in the population.
The reason for the increased or equal uptake of Tc-99m
phytate (sulfur colloid) in FNH compared with that in he-
patic adenoma remains contentious. According to tradi-
tional concepts, hepatic cellular adenomas tend to be cold
because of the loss of their Kupffer cell content. However,
a study conducted by the Armed Forces Institute of Pa-
thology (Washington, DC, USA) demonstrated the presence
of Kupffer cells in 12 cases with hepatic adenoma [25].
Among them, 10 were shown, by hepatic scintigraphy, to be
cold nodules and two to be cool or isoradioactive nodules.
An analysis of the 10 cold nodules revealed that six had a
normal number of Kupffer cells, which was related to a
normal liver, whereas the remaining four nodules had a
decreased number of Kupffer cells. No direct relationshipwas observed in hepatic scintigraphy between the number
of Kupffer cells and the uptake feature of the nodules.
Therefore, the uptake feature of lesions in hepatic scin-
tigraphy is likely related to a combination of factors, such
as the number and functional status of Kupffer cells in
these lesions and blood flow. In our dynamic flow study, we
examined two cases with hypervascularity and the uptake
of the colloid still varied.
We could not find strong evidence of a correlation be-
tween tumor size or localization and its radioactivity up-
take. Notably, almost half of the lesions of our patients
were found in the right hepatic lobe (S7/8), consistent with
the literature (Figures 2 and 4). To our knowledge, there
are no reports with exact declaration. As the hepatic right
lobe constitutes the largest part of the liver, the incidence
of FNH is probably greatest in it. Most of the FNH tumors in
this study (11 of 15) were smaller than 5 cm (Figure 3). The
small FNH tumors (< 5 cm) predominantly exhibited
increased or equal uptake (7 of 11; 64%) for scores above 3.
By contrast, the large FNH tumors (> 5 cm) exhibited a
decreased uptake (3 of 4). In our study, 27% of FNH tumors
were large (> 5 cm); therefore, we observed fewer tumors
(47%) with isoradioactivity or increased radioactivity up-
take. In addition, a change in the microenvironment with
the growth of a tumor will be one of the potential factors
contributing to the alteration of the functional capacity of
Kupffer cells. No statistically significant correlation was
observed between radioactivity uptake and tumor size.
However, small FNH tumors (< 5 cm) seem to exhibit a
trend of increased or equal uptake, providing specificity for
differentiating between solid tumors in CT or MRI imaging.
As Tc-99m phytate or colloid has been used in hepatol-
ogy for decades, this method remains the standard method
for evaluating the functional features of Kupffer cells. We
demonstrated the variable uptake feature of FNH; howev-
er, the traditional warm/hot pattern was exhibited by only
47% of FNH tumors. This does not suggest that the Tc-99m
phytate or colloid study is no longer helpful in the differ-
ential diagnosis of FNH. We emphasize that the cold/cool
tumors cannot be ruled out as FNH. Tumor size and locali-
zation are also provided as reference parameters. The only
limitation of our study was the small sample size. There-
fore, we must include more cases to increase our sample
size and further analyze the molecular status of Kupffer
cells in the future.
Herein, we demonstrated the variable uptake feature of
FNH in Tc-99m phytate scintigraphy. The increased or equal
uptake by small FNH tumors (< 5 cm) still provides speci-
ficity for the differential diagnosis of hepatic solid tumors.References
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